Secret Philip Morris Document Outlining "Sensible" FDA Regulations Uncovered [09/15/04]

Secret Philip Morris Document Outlining "Sensible" FDA Regulations Uncovered [09/15-2]

Excerpts from: 5 Philip Morris principles for FDA regs

By Anne Landman Smokefree.net [09/14/04]

This "Privileged and Confidential" 2000 Philip Morris document was generated during PM's Regulatory Strategy Project , an effort the company began in 1999 to try and enact Food and Drug Administration (FDA) regulations on the company's own terms.

The document lists what PM terms "sensible" FDA regulations. The document is heavily edited by John Holleran of Philip Morris Management's Legal Department. The "Quotes" section (below) contains the document transcribed as it was originally written, without the annotations

The document states, "We [PM] support strong but sensible FDA regulation of cigarettes based on five core principles." The first principal is that FDA "not infringe on the right of adult Americans to choose to take the risks of smoking" and that FDA be prohibited from banning cigarettes and having the power to alter cigarettes to make smoking unpalatable to smokers.

This principal would both preserve a market for cigarettes and assure that cigarettes remain available.

The second requirement is that FDA regulate cigarette design and manufacturing processes "to assure that no additives increase the inherent risks of smoking" and that cigarette ingredients be "fully disclosed to FDA in a framework that protects trade secrets." The simultaneous requirements of full disclosure while maintaining trade secrets seem contradictory, since full disclosure usually means the absence of secrets.

The third principle says that "The long-range goal of FDA regulation should be to reduce the risks of smoking by encouraging industry innovations," and that "FDA should set standards that allow products to be certified as 'reduced risk' and marketed as 'reduced risk.' " This measure seems to have a goal of transferring liability for tobacco products onto the FDA.

The 4th principle PM requires that FDA "assure continuous, updated disclosures to smokers as science evolves so that people continue to be fully informed of the risks of smoking." As it is written, this measure presumes that smokers are already currently fully informed about the risks of smoking, and places the burden of public health education about tobacco products on FDA and not on the manufacturers.

Two alternatives are listed for the fifth requirement, which nominally claims to address youth smoking:

" 5. (Alternative 1) In the area of youth smoking prevention, FDA should set policies that acknowledge the significant changes created by the MSA and, like the MSA, recognize the legitimacy of marketing communications to adult smokers..."

The first alternative it further says that, "Marketing to adults...should not be regulated by the FDA." Instead of addressing youth smoking as the introduction suggests, this principle appears to be aimed at protecting marketing to adults.

The second version of principle #5 says, "FDA should NOT be given a specific regulatory responsibility regarding how cigarettes are marketed and sold. Through the [Master Settlement Agreement], states have a strong legal framework for preventing tobacco marketing to you. The FDA's mission is and should be scientific in nature -- focusing on the products and its risks." The document threatens to embark on a Constitutional legal challenge if FDA makes any effort to regulate tobacco marketing. The second version of principle #5 also says, somewhat haughtily, "There is no need for the FDA to use its scarce resources on youth smoking prevention. That is best left to others."

This paper represents the starting point for laying out the elements of what PM wants in its preferred FDA regulation. Taken as a whole, the document indicates that PM's goals in pressing for FDA regulation are:

1) To assure a future market for cigarettes,
2) To preserve the company's ability to make cigarettes that appeal to their market,
3) To safeguard the company's ability to market cigarettes without restrictions,
4) To keep FDA from engaging in smoking prevention efforts, particularly among youth,
5) To prevent FDA from obtaining any authority to restrict the marketing and promotion of cigarettes,
6) To give FDA the responsibility of fully informing the public about the dangers of tobacco use, rather than the manufacturers,
7) To transfer legal liability for the safety of tobacco products onto the FDA, while allowing cigarette companies the continue to design and market cigarettes as they see fit.

click here to view this official document

Presented as a public service by Action on Smoking and Health (ASH),
2013 H Street, N.W., Wash., DC 20006, USA, (202) 659-4310.
ASH is a 36-year-old national legal-action antismoking and nonsmokers' rights organization which is entirely supported by tax-deductible contributions.
Please credit ASH, and include ASH's web address: http://ash.org

Raising Smoking in a Custody Dispute	Smoking in Condos and Apartments	File Complaints Against Smoking	Toxins in Tobacco Smoke	Dangers of Secondhand Smoke	Govt. Rpt. on Secondhand Smoke
Tobacco Class-Action Law Suits	Sue-Big-Tobacco List of Lawyers	Tobacco Settlement, Multistate	ASH's New International Site	Smoking Facts & Statistics	Children and Smoking